TKIs - Globe Thesis - Globe Thesis

Keyword [TKIs] Result: 21 - 40 \| Page: 2 of 10
21.	Detect Serum Circulating EGFR Mutation With Amplification Refractory Mutation System Method From Patients With Non-small-celi Lung Cancer
22.	Research Progresses Of Resistance Mechanisms And Therapeutic Strategies For Patients With Non-small Cell Lung Cancer After Acquired Resistance To EGFR-TKIs
23.	The Curative Effect Observation Of EGFR-TKIs To Treat Malignant Pleural Effusion Caused By Lung Adenocarcinoma
24.	The Effect Of Caveolin-1on The Sensitivity To TKIs In Non-small Cell Lung Cancer With EGFR Mutations
25.	EGFR-TKIs Contrasted With Chemotherapy As First-line Treatment For Advanced Non-small Cell Lung Cancer: A Meta Analysis
26.	Non-small Cell Lung Cancer Tumor Markers Of Blood Prediction Research Of Epidermal Growth Factor Gene Mutations
27.	Maintenance Chemotherapy For Advanced Non-Small-cell Lung Cancer:a Systematic Review And Meta-analysis
28.	Recurrence Patterns In Patients With Advanced Non-small Cell Lung Cancer After Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
29.	Treatment Of Advanced Non-small Cell Lung Cancer And Study On Circumvention Of Drug Resistance
30.	A Study Of Acquired Resistance Mechanism Of HCC827-TR EGFR Mutant Cell And Afatinib Reversing The Resistance To EGFR-TKIs
31.	The Significance Of Pro-gastrin Releasing Peptide(ProGRP) For Small Cell Lung Cancer Using A Second EGFR-TKI Afer A Severe AE Related To A First EGFR-TKI In NSCLC
32.	The Role Of IGF-1R In The Acquired Resistance Of EGFR Wild-type Non-small Cell Lung Cancer To EGFR-TKIs And Associated Mechanisms
33.	EGFR Mutation Profile, EGFR-TKIs Effecacy Correlated With The Novel Histological Subtypes Based On2011Lung Adenocarcinoma Classification Standard
34.	The Effect Of EGFR-TKIs In Lymphangiogenesis Of Lung Cancer With EGFR Mutations
35.	Design And Synthesis Of 2-Amino-7, 8-Dihydropyrido[4, 3-d]Pyrimidine-6(5H)-YL-Alkoxyl Diaryl Urea Derivatives
36.	Comparison Of Clinical Characteristics And The Effect Of EGFR-TKIs With Non-small Cell Lung Cancer Patients Harbouring EGFR Mutations In Exons19and21
37.	Docetaxel Versus EGFR-TKIs As Second-line Treatment Of Patients With Advanced Non-small-cell-lung Cancer
38.	The Study On Sensitizing Effect Of FuZheng KangAi Decoction With TKIs In Treating EGFR Mutation-negative Advanced NSCLC
39.	Rearch On Comparison EGFR-TKIS With Maintenance Pemetrexed After First-line Chemotherapy For Advanced Non-small Cell Pulmonary Adenocarcinoma With EGFR Mutation
40.	Application Of RECIST1.1 Standards And EORTC Criteria For Evaluating The Efficacy Of Advanced NSCLC Treatment
<<First <Prev Next> Last>> Jump to